322
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Development and Characterization of Self-Microemulsifying Drug Delivery System of Tacrolimus for Intravenous Administration

, &
Pages 619-630 | Published online: 01 May 2009

REFERENCES

  • R. G. Alany, T. Rades, N. M. Davies, and I. G. Tucker. (2000). Effects of alcohols and diols on the phase behaviour of quaternary systems. Int. J. Pharm. 196:141–145.
  • V. B. Borhade. (2006). Study of specialized emulsions for drug delivery. A thesis submitted to University of Mumbai, India, 54–77.
  • H. Chen, X. Chang, Z. Gao, Y. Yang, H. Xu, and X. Yang. (2004). A study of microemulsion systems for transdermal delivery of triptolide. J. Control. Release 58:129–136.
  • E. Christine, and E. Susan. (2004). Clinical pharmacokinetics and pharmacodynamics of FK506 in solid organ transplantation. Clin. Pharmacokinet. 43:623–653.
  • C. V. Corswant, S. Engstrom, and O. Soderman. (1997). Microemulsions based on soybean phosphotidylcholine and triglycerides. Phase behavior and microstructure. Langmuir 13:5061–5070.
  • H. Gelderblom, K. Verweij, and A. Sparreboom. (2001). Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 37:1590–1598.
  • L. He, G. Wang, and Q. Zhang. (2003). An alternative paclitaxel microemulsion formulation: Hypersensitivity evaluation and pharmacokinetic profile. Int. J. Pharm. 250:45–50.
  • T. Kino, H. Hatanaka, M. Hashimoto, M. Nishiyama, T. Goto, M. Okuhara, and M. Kohsaka. (1987). FK506, a novel immunosuppressant isolated from a streptomyces I. Fermentation, isolation and physico-chemical and biological characteristics. J. Antibiot. 42:1249–1255.
  • J. F. Krzyaniak, and D. M. Raymond. (1997). Lysis of human red blood cells 2: Effect of contact time on cosolvents induced hemolysis. Int. J. Pharm. 152:193–200.
  • M. J. Lawrence, and G. D. Rees. (2000). Microemulsion-based media as novel drug delivery systems. Adv. Drug Del. Rev. 45:89–121.
  • M. J. Lee. (1995). Physicochemical pharmacokinetic and pharmacodynamic evaluation of liposomal FK 506 in rats. Pharm. Res. 12:1055–1059.
  • J. M. Lee, K. M. Park, S. J. Lim, and C. K. Kim. (2002). Microemulsion formulation of clonixic acid: Solubility enhancement and pain reduction. J. Pharm. Pharmacol. 54:43–49.
  • L. Li, I. Nandi, and K. H. Kim. (2002). Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam. Int. J. Pharm. 237:77–85.
  • M. A. Moreno, M. P. Ballesteros, and P. Frutos. (2003). Lecithin based oil-in-water microemulsions for parenteral use: Pseudoternary phase diagrams, characterization and toxicity studies. J. Pharm. Sci. 92:1428–1437.
  • Y. Namiki, A. Fujiwara, N. Kihara, S. Koda, and K. Hane. (1995). Factors affecting tautomeric phenomenon of a novel potent immunosuppressant on the design for injectable formulation. Drug Dev. Ind. Pharm. 21:809–822.
  • C. W. Pouton. (2000). Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and “self-microemulsifying” drug delivery systems. Eur. J. Pharm. Sci. 11 (Suppl. 2):S93–S98.
  • L. M. Prince. (1977). Schulman's microemulsions. L. M. Prince. Microemulsions theory and practice. New York: Academic Press, 1–20.
  • H. S. Ruth, D. Attwood, G. Ktistis, and C. J. Taylor. (1995). Phase studies and particle size analysis of oil-in-water phospholipid microemulsions. Int. J. Pharm. 116:253–261.
  • N. Sadurni, C. Solans, N. Azemar, and M. Jose. (2005). Studies on the formation of o/w nano-emulsion, by low-energy emulsification methods, suitable for pharmaceutical applications. Eur. J. Pharm. Sci. 26:438–445.
  • R. Shapiro. (1999). Tacrolimus in solid organ transplantation: An update. Transplant. Proc. 31:2203–2205.
  • T. Shigeki, O. Atsuo, I. Rinta, and L. Gordon. (2002). Tacrolimus is a class II low-solubility high permeability drug: The effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats. J. Pharm. Sci. 91:719–729.
  • E. Soderlind, M. Wollbratt, and C. V. Corswant. (2003). The usefulness of sugar surfactants as solubilizing agents in parenteral formulations. Int. J. Pharm. 252:61–71.
  • C. M. Spencer, K. L. Goa, and J. C. Gillis. (1997). Tacrolimus: An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 54:925–975.
  • R. G. Strickley. (2004). Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21:201–230.
  • M. Trotta, F. Pattarino, and G. Grosa. (1998). Formation of lecithin-based microemulsions containing n-alkanol phosphocholines. Int. J. Pharm. 174:253–259.
  • G. W. Volcheck, and R. G. Dellen. (1998). Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: Case report and review. Ann. Allergy Asthma. Immunol. 80:159–163.
  • P. J. Weller. (2006). Glycofurol. C. R. Raymond, J. S. Paul, and C. O. Sian. Handbook of pharmaceutical excipients. London: Pharmaceutical Press, 313–314.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.